Consolidated Financial Results
for the Fiscal Year Ended June 20, 2023
[Japanese GAAP]
July 24, 2023
Company name: Genky DrugStores Co., Ltd.
Stock exchange listing: Tokyo Stock Exchange
Code number: 9267
URL: http://www.genkydrugstores.co.jp
Representative: Kenichi Fujinaga, President
Contact: Takeshi Tsunemi, Executive Officer, Treasurer and General Manager, IR Division
Phone: +81-776-67-5240
Scheduled date of convention of ordinary general meeting of shareholders: September 7, 2023
Scheduled date of commencing dividend payments: September 8, 2023
Scheduled date of filing annual securities report: September 8, 2023
Availability of supplementary briefing material on annual financial results: Available
Schedule of annual financial results briefing session: Scheduled (for institutional investors and analysts)(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Fiscal Year Ended June 20, 2023 (June 21, 2022 to June 20, 2023)(1) Consolidated Operating Results(% indicates changes from the previous corresponding period.)
Net income
Net sales
Operating income
Ordinary income
attributable to ownersof parentMillion yen%Million yen%

Million yen

Fiscal 2022
169,059 9.3
6,709
18.2
Fiscal 2021
154,639–
5,675–(Note) Comprehensive income: Fiscal 2022: ¥4,796 million (9.2 %)Fiscal 2021: ¥4,393 million ( – %)Net income
per share

Diluted net
income per share

Yen

Net income toshareholders’equity ratio

Yen%

Million yen%

7,079 16.3
6,087
–

4,764
4,420

7.8–

Ordinary income Operating income
to total assets ratio to net sales ratio%%%

Fiscal 2022
313.84313.5912.4
7.0
4.0
Fiscal 2021
291.23290.8812.96.53.7(Reference): Equity in earnings of affiliates: Fiscal 2022: ¥― million
Fiscal 2021: ¥― million(Note) “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29), etc. has been applied from thebeginning of the three months ended September 20, 2021.Therefore, the percentage of changes from theprevious corresponding period in actual figures before applying the standard is not presented.
(2) Consolidated Financial Position
Total assets

Net assets

Million yen

As of June 20, 2023
105,912
As of June 20, 2022
97,118(Reference) Equity: As of June 20, 2023: ¥40,607 million
As of June 20, 2022: ¥36,186 million

Net assets per share

Equity ratio

Million yen%

Yen

40,681
36,23338.3
37.3

2,674.34
2,383.41

(3) Consolidated Cash Flows
Cash flow fromoperating activities

Cash flow frominvesting activities

Cash flow fromfinancing activities

Cash and cash
equivalents at the endof the fiscal year

Million yen

Million yen

Million yen

Million yen

8,773
6,076

(9,736)(10,588)

854
2,037

5,329
5,438

Fiscal 2022
Fiscal 2021

2. Dividends
Annual dividends

Fiscal 2021
Fiscal 2022Fiscal 2023
(Forecast)

1stquarter-end
Yen

2ndquarter-end
Yen

3rdquarter-end
Yen－－

12.50
12.50

－

12.50

Year-end

Total annual
dividends

Total

Dividend
Dividend onpayout ratio equity ratio(consolidated) (consolidated)

Yen

Yen

Million yen

%%－－

12.50
12.50

25.00
25.00

379
379

8.6
8.0

1.1
1.0－

12.50

25.00

7.7

3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 20, 2024 (June 21, 2023 to June 20,2024)(% indicates changes from the previous fiscal year.)
Net income
Net incomeNet sales
Operating income Ordinary income
attributable toper shareowners of parent
First half
Full year

Million yen%

Million yen%

Million yen%

Million yen%

Yen

89,500180,000

6.7
6.5

3,450
7,000

2.5
4.3

3,600
7,250

1.1
2.4

2,340
4,900

3.0
2.8

154.11322.71

Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting inchanges in scope of consolidation): No
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)(2) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: No
2) Changes in accounting policies other than 1) above: No
3) Changes in accounting estimates: No4) Retrospective restatement: No(3) Total number of issued shares (common stock)1) Total number of issued shares at the end of the period (including treasury stock):
As of June 20, 2023: 15,484,384 shares
As of June 20, 2022: 15,482,884 shares2) Total number of treasury stock at the end of the period:
As of June 20, 2023: 300,414 shares
As of June 20, 2022: 300,380 shares
3) Average number of shares during the period:
Year ended June 20, 2023: 15,182,958 sharesYear ended June 20, 2022: 15,179,544 shares

(Reference) Summary of Non-Consolidated Financial Results
Non-Consolidated Financial Results for the Fiscal Year Ended June 20, 2023 (June 21, 2022 to June 20, 2023)(1) Non-Consolidated Operating Results(% indicates changes from the previous fiscal year.)Net sales
Operating income
Ordinary income
Net income
Fiscal 2022
Fiscal 2021

Million yen%

Million yen%Million yen%

Million yen%

619
318

95.0
0.0

422
113

272.7
(19.7)

898
611

47.0
177.6

705
411

71.7
211.1

Net income per share
Fiscal 2022
Fiscal 2021

Diluted net income
per share

Yen

Yen

46.50
27.09

46.46
27.06

(2) Non-Consolidated Financial Position
Total assets

Net assets

Million yen

As of June 20, 2023
22,009As of June 20, 2022
21,930(Reference) Equity: As of June 20, 2023: ¥21,700 million
As of June 20, 2022: ¥21,369 million

Net assets per share

Equity ratio

Million yen%

Yen

21,774
21,41798.6
97.41,429.15
1,407.50* These financial results are outside the scope of audit by a certified public accountant or an audit corporation.
* Explanation of the proper use of financial results forecast and other notes
The earnings forecasts and other forward-looking statements herein are based on information that is available andcertain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ
significantly from these forecasts due to a wide range of factors.